原发性肾病综合征免疫抑制剂治疗合并呼吸道感染的危险因素

    Risk factors of complicated respiratory tract infection inimmunosuppressive therapy of primary nephrotic syndrome

    • 摘要: 目的 了解原发性肾病综合征(primary nephrotic syndrome,PNS)患者并发呼吸道感染的临床特征与危险因素。方法 选取2015年1月至2017年7月于徐州医科大学附属医院肾脏内科初诊初治的PNS患者203例,其中并发呼吸道感染者156例(76.8%),上呼吸道感染105例(51.7%),下呼吸道感染51例(25.1%),回顾性分析其临床特征及危险因素。结果 PNS患者免疫治疗过程中上呼吸道感染发病率18.2%~24.1%,下呼吸道感染发病率第2个月最高6.1%。各个组肾脏病理类型无明显差异。下呼吸道感染组较无呼吸道感染组年龄较大、心率较快、单日激素剂量较高,血淋巴细胞计数、单核细胞计数、血红蛋白、血清白蛋白、免疫球蛋白G(IgG)、估算肾小球滤过率(eGFR)水平较低;尿素、肌酐、尿免疫球蛋白G,C反应蛋白(CRP)、乳酸脱氢酶(lactate dehydrogenase,LDH)较高。低免疫球蛋白G、淋巴细胞、白蛋白水平,激素联合免疫抑制剂使用是下呼吸道感染独立危险因素。结论 PNS患者病程中上呼吸道感染发病率均较高,下呼吸道感染发病率在接受免疫治疗第2个月最高,合并低免疫球蛋白G、低淋巴细胞、白蛋白水平、使用激素联合免疫抑制剂患者易下呼吸道感染。

       

      Abstract: Objective To investigate the clinical features and risk factors of complicated respiratory tract infection of primary nephrotic syndrome (PNS). Methods From January 2015 to July 2017, 203 patients with PNS in the nephrology department of our hospital were selected, among whom 156 ones (76.8%) were complicated with respiratory tract infection, 105 ones (51.7%) with upper respiratory tract infection, and 51 ones (25.1%) with lower respiratory tract infection. The clinical characteristics and risk factors were retrospectively analyzed. Results During immunotherapy, the incidence of upper respiratory tract infection in PNS patientswas 18.2%~24.1%, and the incidence of lower respiratory tract infection reached the highest value of 6.1% in the second month.There were no significant differences in renal pathological types between the groups.The patients with lower respiratory tract infection, their ages had greater age, faster heart beat, higher singly daily hormone dose,lower lymphocyte count, monocyte count, hemoglobin, serum albumin, Immunoglobulin G (IgG) andestimated glomerular filtration rate (eGFR) level, and higher urea, creatinine, urinary immunoglobulin G, c-reactive protein (CRP), lactate dehydrogenase (LDH).Low immunoglobulin G, lymphocyte, albumin levels, and hormone combined immunosuppressant use were independent risk factors for lower respiratory tract infection. Conclusions In the pathological progression of PNS patients, the incidence of upper respiratory tract infection is higher, and the incidence of lower respiratory tract infection is the highest in the second month of immunotherapy. Patients with low immunoglobulin G, low lymphocyte and albumin levels, combined with hormone and immunosuppressive drugs, are prone to lower respiratory tract infection.

       

    /

    返回文章
    返回